[ASND] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
23-May-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -22.14%
YoY- -131.13%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 1,436 3,211 18 444 1,136 1,943 3,913 -15.37%
PBT -95,038 -58,969 -22,876 -30,743 -13,359 -15,323 -2,108 88.54%
Tax -106 -65 -99 -37 -74 -284 30 -
NP -94,932 -58,904 -22,777 -30,706 -13,285 -15,039 -2,138 88.06%
Tax Rate - - - - - - - -
Total Cost 96,368 62,115 22,795 31,150 14,421 16,982 6,051 58.55%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -6,610.86 -1,834.44 -126,538.89 -6,915.77 -1,169.45 -774.01 -54.64 122.23%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -1.97 -1.25 -0.55 -0.94 -0.53 -0.63 -0.20 46.35%
EPS Diluted -1.97 -1.25 -0.55 -0.94 -0.53 -0.63 -0.20 46.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.